Total Funding
60
41
Total FundingDebt Financing raised
Growth Score
-1 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
157105
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.
- Malcolm A. Meyn: Co-Founder and CSO
About the Company
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia. The company was founded in 2020 and is headquartered in Chapel Hill, North Carolina, United States.
